RXLProShares Ultra Health Care
Seeks daily investment results that correspond to 2x the daily performance of the S&P Health Care Select Sector Index.
By ProShares · Launched 2007
Annual Cost
0.95%
#4,962 of 6,062 · expensive
Fund Size
$96M
#3,146 of 6,062 · mid-size
Return (1Y)
+45.0%
Track Record
19 years
#425 of 6,062 · established
Performance
Total-return NAV · USDGrowth of $10,000
$14,055+40.5%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Sector
Health careIndex tracked
S&P Health Care Select Sector Index
Holdings
By weightConcentration
synthetic exposure — holdings shown are derivatives collateral, not the fund's positions
ProShares GENIUS Money Market ETF
10.7%
Eli Lilly & Co.
10.2%
Johnson & Johnson
7.3%
AbbVie, Inc.
5.0%
Merck & Co., Inc.
3.8%
UnitedHealth Group, Inc.
3.3%
Amgen, Inc.
2.6%
Abbott Laboratories
2.5%
Thermo Fisher Scientific, Inc.
2.4%
Gilead Sciences, Inc.
2.3%
Asset allocation
Stocks
73.0%
Cash
15.5%
Other
11.5%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
32.4%High
Year-on-year price swings
Max drawdown
-51.0%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.39Below average
Sortino (3Y)
0.56Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results that correspond to 2x the daily performance of the S&P Health Care Select Sector Index.
- Strategy
- Invests in financial instruments to achieve daily returns consistent with the Daily Target, aiming for 2x exposure to the S&P Health Care Select Sector Index. Focuses on health care companies in the U.S., primarily through derivatives and equity securities of the largest companies.
- Inception date
- January 30, 2007
- Fund family
- ProShares
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save RXL to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-19